DENTSPLY SIRONA (NASDAQ:XRAY) Issues Quarterly Earnings Results

DENTSPLY SIRONA (NASDAQ:XRAYGet Rating) announced its quarterly earnings data on Monday. The medical instruments supplier reported $0.41 earnings per share for the quarter, missing the consensus estimate of $0.59 by ($0.18), Briefing.com reports. DENTSPLY SIRONA had a net margin of 8.27% and a return on equity of 10.18%. The company had revenue of $947.00 million during the quarter, compared to analyst estimates of $1.01 billion. During the same period in the prior year, the firm earned $0.68 earnings per share. DENTSPLY SIRONA’s revenue was down 8.9% on a year-over-year basis. DENTSPLY SIRONA updated its FY 2022 guidance to $1.90-$2.00 EPS and its FY22 guidance to $1.90-2.00 EPS.

DENTSPLY SIRONA Price Performance

XRAY stock traded down $0.74 during midday trading on Wednesday, reaching $30.60. 55,425 shares of the stock were exchanged, compared to its average volume of 2,599,078. The stock has a market capitalization of $6.58 billion, a PE ratio of 12.00, a P/E/G ratio of 3.46 and a beta of 0.95. DENTSPLY SIRONA has a 52 week low of $26.48 and a 52 week high of $58.70. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.52 and a quick ratio of 1.05. The company has a fifty day moving average price of $30.04 and a 200 day moving average price of $34.31.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the company. TheStreet cut DENTSPLY SIRONA from a “c” rating to a “d” rating in a report on Monday. Piper Sandler lowered their price target on DENTSPLY SIRONA from $38.00 to $29.00 in a report on Monday. Morgan Stanley lowered their price target on DENTSPLY SIRONA from $42.00 to $39.00 and set an “overweight” rating for the company in a report on Tuesday. William Blair reissued an “underperform” rating on shares of DENTSPLY SIRONA in a report on Tuesday, November 1st. Finally, StockNews.com assumed coverage on DENTSPLY SIRONA in a report on Wednesday, October 12th. They set a “hold” rating for the company. One analyst has rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $44.56.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. grew its position in shares of DENTSPLY SIRONA by 1.2% in the 3rd quarter. Vanguard Group Inc. now owns 24,732,513 shares of the medical instruments supplier’s stock valued at $701,167,000 after buying an additional 297,487 shares during the last quarter. Wellington Management Group LLP grew its position in shares of DENTSPLY SIRONA by 83.1% in the 1st quarter. Wellington Management Group LLP now owns 5,502,424 shares of the medical instruments supplier’s stock valued at $270,829,000 after buying an additional 2,497,773 shares during the last quarter. Dimensional Fund Advisors LP grew its position in shares of DENTSPLY SIRONA by 6.9% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,833,372 shares of the medical instruments supplier’s stock valued at $90,243,000 after buying an additional 117,571 shares during the last quarter. Charles Schwab Investment Management Inc. grew its position in shares of DENTSPLY SIRONA by 2.1% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 1,665,157 shares of the medical instruments supplier’s stock valued at $81,959,000 after buying an additional 34,199 shares during the last quarter. Finally, Goldman Sachs Group Inc. grew its position in shares of DENTSPLY SIRONA by 6.8% in the 2nd quarter. Goldman Sachs Group Inc. now owns 564,665 shares of the medical instruments supplier’s stock valued at $20,175,000 after buying an additional 36,122 shares during the last quarter. Institutional investors own 96.00% of the company’s stock.

DENTSPLY SIRONA Company Profile

(Get Rating)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products.

See Also

Earnings History for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.